The Underregulation of Carcinogen Exposure
Scholar calls for Congress to empower regulators to limit exposure to cancer-causing chemicals.
Open Data, Closed Doors?
Better regulation can eliminate high-cost barriers to the integration of electronic health records.
Navigating Genetic Data Privacy and Law Enforcement Access
Scholars discuss the regulatory landscape surrounding genetic data privacy.
Reducing Barriers to Glucose Monitoring
FDA approves first over-the-counter continuous glucose monitor for U.S. patients.
The Past, Present, and Future of EMTALA
Scholars discuss EMTALA’s effects on physicians and argue for its continued use.
Forces that Shape and Constrain Medical Practice
Michelle Mello discusses how the law, artificial intelligence, and the COVID-19 pandemic have shaped health care.
Regulatory Collaboration to Protect Public Health
Noah Aleshire, chief regulatory officer at the CDC, discusses the value of a collaborative and informed regulatory process.
FDA Targets Toxic Soda Ingredients
FDA proposes a rule that would prohibit the use of a toxic food additive in sodas.
The Growing Crisis of Maternity Care Deserts
Scholars, politicians, and advocates expose maternal health care disparities and propose regulatory solutions.
Access Barriers Remain After Abortion Pill Decision
The Court rejected a challenge to FDA approval of mifepristone, but other obstacles could still impede access.
Establishing Regulatory Guardrails for Elderly Drivers
Scholars urge state lawmakers to strengthen driving regulations for seniors to address public safety concerns.